PASTEUR MERIEUX CONNAUGHT VACCINE SALES GROW 41% IN U.S. DURING 1997; MERCK VACCINES UP 27.5%: COZAAR, CRIXIVAN AND FOSAMAX COMBINE FOR $1 BIL. IN U.S.
Executive Summary
Pasteur Merieux Connaught vaccine sales in the U.S. increased by 41% during 1997 on the strength of Tripedia (pertussis, diphtheria, tetanus) and Ipol (injectable polio), Rhone-Poulenc said Jan. 29.